United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$29Mraised across 6 rounds since 2012, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $3.6M sold, first sale Jan 2018
Reported by FinSMEsSEC filing: $3.6M sold, first sale Jan 2018
Founders FundReported by FinSMEsSEC filing: $2.7M sold, first sale Oct 2016
No investor was named in the report.
From a historical funding recordSEC filing: $375K sold, first sale Aug 2015
From a historical funding recordSEC filing: $2.4M sold, first sale Aug 2014
From Immusoft's own website and the SEC filings it signed: 1 founder, 3 on the team.
On the board, as filediAnthony SunCam Gallahger
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Founders Fund
Alexandria Real Estate Equities
DEFTA Partners
The Thiel FoundationFF Science
RBV CapitalMesa Verde600 Mile Challenge FundBreakoutTechnium PartnersMissing a round, or an investor who was in one? Tell us.
These 7 firms list Immusoft as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Immusoft's investors include Founders Fund, Alexandria Real Estate Equities, DEFTA Partners, The Thiel Foundation and FF Science, and 5 more on record.
Immusoft has raised $29M across 6 rounds since 2012.
Immusoft's most recent round was a Series B of $3.0M in Jan 2018.
Immusoft's largest round on record is $20M (Series B), in Jan 2018.
Immusoft's first round on record, in Apr 2012, was backed by The Thiel Foundation.
Immusoft's latest named round is a Series B, in Jan 2018.
Immusoft is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
